Walgreens Boots Alliance (NASDAQ:WBA) Issues Quarterly Earnings Results, Beats Expectations By $0.13 EPS

Walgreens Boots Alliance (NASDAQ:WBA) posted its quarterly earnings data on Friday. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13, RTT News reports. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter in the prior year, the company earned $0.66 earnings per share. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. Walgreens Boots Alliance updated its FY 2025 guidance to 1.400-1.800 EPS and its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $9.22 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance has a 1-year low of $8.08 and a 1-year high of $25.63. The business has a 50 day simple moving average of $9.21 and a two-hundred day simple moving average of $9.92. The stock has a market capitalization of $7.96 billion, a PE ratio of -0.92, a P/E/G ratio of 1.36 and a beta of 0.64.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a $0.25 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.85%. Walgreens Boots Alliance’s dividend payout ratio is currently -9.99%.

Analyst Ratings Changes

WBA has been the subject of a number of analyst reports. Morgan Stanley reduced their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research note on Friday, October 11th. Royal Bank of Canada lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research note on Wednesday, December 4th. TD Cowen cut their target price on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, October 22nd. Jefferies Financial Group dropped their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Finally, Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday, October 7th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.